Conexeu Sciences, Inc. (CNXU)
3.10
-0.20
(-6.06%)
USD |
NASDAQ |
Oct 23, 16:00
3.31
+0.21
(+6.77%)
Pre-Market: 20:00
Conexeu Sciences Shareholders Equity (Quarterly) : 5.850M for July 31, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 5.850M |
| April 30, 2026 | 7.196M |
| October 31, 2025 |
| Date | Value |
|---|---|
| April 30, 2025 | |
| October 31, 2024 | 0.095M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vericel Corp. | 370.04M |
| AbbVie, Inc. | -5.935B |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.156M |
| Total Liabilities (Quarterly) | 1.306M |
| Debt to Equity Ratio | 0.0124 |
| Current Ratio | 5.310 |
| Net Debt Paydown Yield | 0.00% |